+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GENNEX GENNEX

Gennex Laboratories Share Price

₹8.97 +0 (0%)
39.80% Fall from 52W High

20 Nov, 2026 10:27 AM (IST)

Gennex Laboratories live price: ₹8.97. It opened at ₹9 vs previous close ₹9; intraday high/low: ₹9/₹9. The 50 & 200 DMA stand at ₹9.50/₹10.50.

Gennex Laboratories Performance

  • Today's Low
  • ₹9
  • Today's High
  • ₹9
  • 52 Week Low
  • ₹7
  • 52 Week High
  • ₹15
  • Open Price₹9
  • Previous Close₹9
  • Volume18,458
  • 50 DMA₹9.50
  • 100 DMA₹9.90
  • 200 DMA₹10.50

Gennex Laboratories Chart

Investment Returns

  • Over 1 Month + 0%
  • Over 3 Month -23.79%
  • Over 6 Month -18.08%
  • Over 1 Year -38.6%

Smart Investing Starts Here Start SIP with Gennex Laboratories for Steady Growth!

Invest Now

Gennex Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12
  • PEG Ratio
  • -0.6
  • Market Cap Cr
  • 218
  • P/B Ratio
  • 1
  • Average True Range
  • 0.5
  • EPS
  • 0.7
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.1
  • RSI
  • 46.33
  • MFI
  • 58.79

Latest Stock News Updates

Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication on Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half year ended September 30, 2026 announced by the Board of Directors in its meeting held on Saturday, November 14, 2026. Financial results had been published in both Business Standard (English) and Saksham (Telugu - Local) on November 17, 2026. We request you to take the above information on record and acknowledge receipt of the same.

Gennex Laboratories Ltd - 531739 - Intimation Regarding Dissolution Of The Rights Issue Committee Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., November 14, 2026, has approved the dissolution of the Rights Issue Committee with immediate effect i.e., November 14, 2026. The Rights Issue Committee was originally constituted by the Board of Directors to oversee, decide upon, and execute matters relating to the Company''s Rights Issue of equity shares. Since the Rights Issue has been duly completed and all related formalities, including the listing and trading approvals, have been concluded, the purpose for which the Committee was formed stands fulfilled. This intimation is also uploaded on the Company website i.e., www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

Gennex Laboratories Ltd - 531739 - Intimation Of Reconstitution Of Audit Committee, Stakeholders Relationship Committee And Nomination And Remuneration Committee Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015.

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their meeting held on November 14, 2026, reconstituted Audit Committee, Stakeholders Relationship Committee and Nomination and Remuneration Committee with immediate effect. This intimation is also uploaded on the Company website i.e. www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

Gennex Laboratories Financials

Gennex Laboratories Technicals

EMA & SMA

Current Price
₹8.97
0 (0%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹9.10
  • 50 Day
  • ₹9.50
  • 100 Day
  • ₹9.90
  • 200 Day
  • ₹10.50

Resistance and Support

8.92 Pivot Speed
  • R3 9.30
  • R2 9.20
  • R1 9.10
  • S1 8.90
  • S2 8.80
  • S3 8.70

Gennex Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-14 Quarterly Results
2026-09-04 A.G.M.
2026-08-14 Quarterly Results
2026-05-30 Audited Results
2026-04-16 Others Inter-alia, to consider 1. Decide regarding the conduct of EGM for Regularization of Additional Director Ms. Khushbu Kachhawa as a Director. 2. Appoint Scrutinizer for EGM. 3. Other business matters.
Date Purpose Remarks
2009-12-15 Split

Gennex Laboratories Shareholding Pattern

76.36%
23.63%
0%

Gennex Laboratories FAQs

Gennex Laboratories share price is ₹8 As on 20 November, 2026 | 10:13

The Market Cap of Gennex Laboratories is ₹217.9 Cr As on 20 November, 2026 | 10:13

The P/E ratio of Gennex Laboratories is 12 As on 20 November, 2026 | 10:13

The PB ratio of Gennex Laboratories is 1 As on 20 November, 2026 | 10:13

The 52 week High & Low of Gennex Laboratories is ₹14.9/₹7 respectively As on 20 November, 2026 | 10:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23